SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 278 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $444,000 | -59.2% | 5,964 | -6.5% | 0.01% | -62.9% |
| Q4 2020 | $1,087,000 | +25.2% | 6,377 | +3.1% | 0.04% | +9.4% |
| Q3 2020 | $868,000 | -30.4% | 6,183 | -20.5% | 0.03% | -33.3% |
| Q2 2020 | $1,247,000 | +74.6% | 7,779 | +6.5% | 0.05% | +45.5% |
| Q1 2020 | $714,000 | -27.0% | 7,301 | -3.6% | 0.03% | +3.1% |
| Q4 2019 | $978,000 | +54.5% | 7,576 | -9.9% | 0.03% | +52.4% |
| Q3 2019 | $633,000 | -51.5% | 8,410 | -2.1% | 0.02% | -51.2% |
| Q2 2019 | $1,305,000 | +9.9% | 8,590 | -13.7% | 0.04% | +13.2% |
| Q1 2019 | $1,187,000 | -76.2% | 9,959 | -78.2% | 0.04% | -78.4% |
| Q4 2018 | $4,994,000 | -30.9% | 45,763 | +2.3% | 0.18% | -17.0% |
| Q3 2018 | $7,222,000 | +8.7% | 44,714 | -11.0% | 0.21% | +7.6% |
| Q2 2018 | $6,641,000 | +10.2% | 50,245 | -38.2% | 0.20% | -4.4% |
| Q1 2018 | $6,026,000 | -5.9% | 81,330 | -29.3% | 0.21% | -5.5% |
| Q4 2017 | $6,401,000 | +14.9% | 115,042 | -6.3% | 0.22% | +14.7% |
| Q3 2017 | $5,569,000 | – | 122,790 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |